Tina M. Larson is the President and Chief Operating Officer at Recursion, a clinical-stage biotechnology company industrializing drug discovery by decoding biology. She has built a career at the intersection of bioengineering and mission-driven businesses seeking to improve lives. Ms. Larson is a 20+ year veteran of the biopharmaceutical industry; prior to joining Recursion she held senior leadership roles at Genentech, Roche and Achaogen. She has a unique ability to solve complex organizational challenges while also building and empowering exceptional leaders and teams to solve problems and drive innovation. Since Ms. Larson joined Recursion as COO in 2018, the company has significantly scaled its size and capabilities.
Ms. Larson serves as board chair for antimicrobial company Revagenix, and serves on advisory boards for the Utah System of Higher Education Deep Technology Initiative and Colorado State University’s College of Engineering. Ms. Larson is an advocate for advancing women in engineering and business, and has been recognized as a CSU Distinguished Alumni, Healthcare Businesswomen’s Association Rising Star, and a Women Tech Awards winner. She holds a B.S. in Chemical Engineering from Colorado State University.
